Distinct tau neuropathology and cellular profiles of an APOE3 Christchurch homozygote protected against autosomal dominant Alzheimer’s dementia

We describe in vivo follow-up PET imaging and postmortem findings from an autosomal dominant Alzheimer’s disease (ADAD) PSEN1 E280A carrier who was also homozygous for the APOE3 Christchurch (APOE3ch) variant and was protected against Alzheimer’s symptoms for almost three decades beyond the expected...

Descripción completa

Detalles Bibliográficos
Autores principales: Sepulveda-Falla, Diego, Sanchez, Justin S., Almeida, Maria Camila, Boassa, Daniela, Acosta-Uribe, Juliana, Vila-Castelar, Clara, Ramirez-Gomez, Liliana, Baena, Ana, Aguillon, David, Villalba-Moreno, Nelson David, Littau, Jessica Lisa, Villegas, Andres, Beach, Thomas G., White, Charles L., Ellisman, Mark, Krasemann, Susanne, Glatzel, Markus, Johnson, Keith A., Sperling, Reisa A., Reiman, Eric M., Arboleda-Velasquez, Joseph F., Kosik, Kenneth S., Lopera, Francisco, Quiroz, Yakeel T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381462/
https://www.ncbi.nlm.nih.gov/pubmed/35838824
http://dx.doi.org/10.1007/s00401-022-02467-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381462/
https://www.ncbi.nlm.nih.gov/pubmed/35838824
http://dx.doi.org/10.1007/s00401-022-02467-8

Ejemplares similares